Back to Legal & General Group Plc Legal & General Group Plc

MCRBMCRB

Showing 0 of 23 quarters

Position history for Legal & General Group PlcLegal & General Group Plc's holdings in SERES THERAPEUTICS INC

No. Legal & General Group exited its MCRB (Seres Therapeutics) position in Q2 2024. Its Q1 2024 13F listed 9,985 shares worth $7,729. Legal & General Group already held MCRB in its Q4 2018 13F, the earliest on record, and held it in 22 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used